Piramal Builds GI Play With OTC Acquisitions
This article was originally published in Scrip
Executive Summary
Piramal Enterprises' consumer products unit has acquired five brands from Organon India Pvt Ltd and MSD BV for INR920m ($13.8m), as it expands its offering in the fast growing gastrointestinals segment in India.
You may also be interested in...
Piramal Stays The M&A Course; Snaps Up Niche Mallinckrodt Assets
India’s Piramal group continues its buying spree, snapping up Mallinckrodt’s intrathecal therapy business, as it seeks limited competition niches to plough deeper into the $20bn-plus global generic injectable hospital drugs market.
Deals, Divestitures In Store As Dr Reddy’s Stays Course To Top Five India League
Investments in differentiated and specialty products and collaborations, alongside divestitures, are part of Dr Reddy’s plans as it seeks to move up the rankings in India. Momentum in China, including an alliance with Sunflower Pharma for orphan diseases, is also being keenly watched.
Deals, Divestitures In Store As Dr Reddy’s Stays Course To Top 5 India League
Investments in differentiated and specialty products and collaborations, alongside divestitures, are part of Dr Reddy’s plans as it seeks to move up the rankings in India. Momentum in China, including an alliance with Sunflower Pharma for orphan diseases, is also being keenly watched.